Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


A review is devoted to a comorbidity of myocardial infarction and anxious and depressive disorders. In the first part (Rational Pharmacother. Cardiol. 2007;3:41-51) data concerning prevalence of depression in myocardial infarction, pathophysiological mechanisms connecting depression and ischemic heart disease (IHD) were given. Influence of concomitant depressive disorders on clinical state and forecast of patients after myocardial infarction was discussed. The second part of the review is devoted to the anxious disorders in myocardial infarction as well as to influence of anxious and depressive disorders on life quality of patients with myocardial infarction. Besides, contemporary approaches to the therapy of anxious and depressive disorders in patients with IHD are discussed.

About the Authors

Y. A. Vasyuk
Moscow State Medical Stomatological University
Russian Federation
Department of clinical functional diagnostics

A. V. Lebedev
Moscow State Medical Stomatological University
Russian Federation
Department of clinical functional diagnostics


1. Antman E.M., Anbe D.T,. Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the management of patients with acute myocardial infarction). 2004. Available at http://www.acc. org/qualityandscience/clinical/guidelines/stemi/Guideline1/index.htm

2. Корнетов H.A., Лебедева E.B. Депрессивные расстройства у пациентов, перенесших инфаркт миокарда. Психиатрия и психофармакотерапия 2003;5(5):195-8.

3. Bush D.E., Ziegelstein R.C., Patel U.V., et al. Post-myocardial infarction depression. Evidence Report/Technology Assessment No. 123. (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-02-0018.) AHRQ Publication No. 05-E018-2. Rockville, MD: Agency for Healthcare Rese￾arch and Quality. May 2005.

4. Carney R.M., Freedland K.E., Miller G.E., Jaffe A.S. Depression as a risk factor for cardiac mortality and morbidity. A review of potential mechanism. J Psychosom Res 2002; 53: 897-902

5. Musselman D.L., Evans D.L., Nemeroff Ch.B. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998;55:580-92.

6. Rozanski A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-217.

7. Sheps D.S., Rozansky A. From feeling blue to clinical depression: exploring the pathogenicity of depressive symptoms and their management in cardiac practice. Psychosom Med 2005; 67 Suppl 1: S2-S5.

8. Погосова Г.В., Жидко Н.И., Михеева Т.Г., Байчоров И.Х. Клиническая эффективность и безопасность циталопрама у больных с депрессией после пере- несенного инфаркта миокарда. Кардиология 2003;(1): 24-9.

9. Соколов Е.И., Барденштейн Л.Н. Применение сертралина при терапии депрессии после перенесенного инфаркта миокарда. Вестник Смоленской медицинской академии 2001;(3): 101-2.

10. Стаценко М.Е., Рыбак В.А., Говоруха О.А. Коррекция тревожно-депрессивных расстройств тианептином у больных с сердечной недостаточностью в раннем постинфарктном периоде. Кардиология 2005;(12):40-52.

11. Glassman A.H., O’Connor Ch.M., Califf R.M., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288: 701-9.

12. The ENRICHD Investigators. Effects of treating depression and low perceived social support on clinical events after a myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003;289 (23):3106-16.

13. Васюк Ю.А., Довженко Т.В., Ющук Е.Н., Школьник Е.Л. Диагностика и лечение депрессий при сердечно-сосудистой патологии. М.: ГОУ ВУНМЦ; 2004.

14. Сыркин А.Л. Ишемическая болезнь сердца и соматизированные депрессии: особенности клиники, дифференциальной диагностики и терапевтических подходов. Consilium Medicum 2003; (экстравыпуск): 7-9.

15. Frasure-Smith N., Lesperance F., Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005.

16. Lauzon C., Beck C.A., Huynh T., et al. Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ 2003;168(5): 547-552.

17. Brundtland G.H. Mental health in the 21st century. Bulletin of the World Health Organization 2000;78:411.

18. МКБ-10: Международная статистическая классификация болезней и проблем, связанных со здоровьем. В 3-х томах. M.: Медицина; 2004.

19. Guck T.P., Kavan M.G., Elsasser G.N., Barone E.J. Assessment and treatment of depression following myocardial infarction. Am Fam Physician 2001;64:641-8.

20. Чазов Е.И., Оганов Р.Г., Погосова Г.В. и соавт. Клинико-эпидемиологическая программа изучения депрессии в кардиологической практике у больных артериальной гипертонией и ишемической болезнью сердца (КООРДИНАТА): первые результаты многоцентрового исследования. Кардиология 2005;(11):4-10.

21. Amin A.A, Jones A.M.H., Nugent K., et al. The prevalence of unrecognized depression in patients with acute coronary syndrome. Am Heart J 2006;152:928- 34.

22. Huffman J.C., Smith F.A., Blais M.A., et al. Recognition and treatment of depression and anxiety in patients with acute myocardial infarction. Am J Cardiol 2006;98:319-24.

23. Ziegelstein R.C., Kim S.Y., Kao D., et al. Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening? Psychosom Med 2005;67:393-7.

24. Оганов Р.Г., Ольбинская Л.И., Смулевич А.Б. и соавт. Депрессии и расстройства депрессивного спектра в общемедицинской практике. Результаты программы КОМПАС. Кардиология 2004;(1):48-54.

25. Качковский М.А., Крюков Н.Н. Лечение депрессии у больных инфарктом миокарда тианептином. Кардиология 2006;(5):21-6.

26. Сыромятникова Л.И., Шестаков В.В., Зубарев М.А. Особенности депрессивных нарушений у больных с ОИМ. Материалы симпозиума "Психовегетативные синдромы у терапевтических больных" XII Российского национального конгресса "Человек и лекарство". М.; 2000. c.18-22.

27. Frasure-Smith N., Lesperance F., Juneau M., et al. Gender, depression, and oneyear prognosis after myocardial infarction. Psychosom Med 1999;61:26-37.

28. Mallik S., Spertus J.A., Reid K.J., et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med 2006;166:876-83.

29. Naqvi T.Z., Naqvi S.S., Merz C.N. Gender differences in the link between depression and cardiovascular disease. Psychosom Med 2005; 67 Suppl 1:S15-S18.

30. Погосова Г.В. Депрессия и сердечно-сосудистые заболевания. Кардиология 2004;(4):32-4.

31. Frasure-Smith N., Lesperance F., Gravel G., et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res 2000; 8: 471-8.

32. Watkins L.L., Schneiderman N., Blumenthal J.A., et al. Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am Heart J 2003;146:48-54.

33. Lesperance F., Frasure-Smith N., Talajic M.D. Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996;58:99- 110.

34. Martens E.J., Denollet J., Pedersen S.S., et al. Relative lack of depressive cognitions in post-myocardial infarction depression. J Affect Disord 2006;94:231-7.

35. Dijkstra J.B. , Strik J.J.M.H., Lousberg R., et al. Atypical cognitive profile in patients with depression after myocardial infarction. J Affect Disord 2002;70:181- 90.

36. Chapagain G., Rajbhandari K.C., Sharma V.D. A study of symptom profile of depression following myocardial infarction. Nepal Med Coll J 2003;5:92-4.

37. Dickens Ch., Percival C., McGowan L., et al. The risk factors for depression in first myocardial infarction patients. Psychol Med 2004;34:1083-92.

38. Spijkerman T.A., de Jonge P., van den Brink R.H.S., et al. Depression following myo￾cardial infarction: first-ever versus ongoing and recurrent episodes. Gen Hosp Psychiatry 2005;27:411-7.

39. Spijkerman T.A., van den Brink R.H.S., Jansen J.H.C., et al. Who is at risk of post￾MI depressive symptoms? J Psychosom Res 2005;58:425-32.

40. Gillespie Ch.F., Nemeroff Ch.B. Hypercortisolemia and depression. Psychosom Med 2005;67 Suppl 1:S26-S28.

41. Jacobson L., Sapolsky R.M. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991;12:118-34.

42. Plotsky P.M., Owens M.J., Nemeroff C.B. 1998. Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998;21:293-307.

43. Young E. A., Haskett R. F., Murphy-Weinberg V., еt al. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 1991;48:693-9.

44. Bjorkerud S. Effect of adrenocortical hormones on the integrity of rat aortic endothelium. In: Schettler G., Weizel A. eds. Proceedings of the 3rd International Symposium on Atherosclerosis. Berlin: Springer-Verlag; 1973.

45. Gold P.W., Chrousos G.P. The endocrinology of melancholic and atypical depression: relation to neurocircuity and somatic consequences. Proc Assoc Am Physicians 1999;111:22-34.

46. Ross R., Harker L. Hyperlipidemia and atherosclerosis. Science 1976;193:1094- 100.

47. Carney R.M., Freedland K.E., Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 2005;67 Suppl 1:S29-S33.

48. Roy A., Pickar D., De Jong J., et al. Norepinephrine and its metabolites in cerebrospinal fluid, plasma and urine: relationship to hypothalamic-pituitary-adrenal axis function in depression. Arch Gen Psychiatry 1988;45:849-57.

49. Wittstein I.S., Thiemann D.R., Lima J.A.C., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539-48.

50. Agelink M.W., Boz C., Ullrich H., et al. Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Res 2002;113:139-49.

51. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society for Pacing and Electrophysiology. Circulation 1996;93:1043-65.

52. Fouad F.M., Tarazzi R.C., Gerrario C.M., et al. Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Phisiol 1984;246:H838-842.

53. Koizumi K., Terui N., Kollai M. Effect of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic fluctuations. J Autonom Nerv Syst 1985;12:251-259.

54. Kleiger R.E., Miller J.P., Bigger J.T. Jr, Moss A.J. Decreased heart rate variability and its association with mortality after myocardial infarction. Am J Cardiol 1987;113:256-62.

55. Vaishnav S., Stevenson R., Marchant B., et al. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol 1994;73:653-7.

56. Carney R.M., Freedland K.E., Rich M.W., et al. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993; 95:23- 8.

57. Coto E., Reguero J.R., Alvarez V., et al. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clinical Science 2003;104:241-5.

58. Fumeron F., Betoulle D., Nicaud V., et al. Serotonin Transporter Gene Polymorphism and Myocardial Infarction. Etude Cas-Tmoins de l’Infarctus du Myocarde (ECTIM). Circulation 2002;105:2943-5.

59. Lesch K.P., Bengel D., Heils A., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-31.

60. Williams R.B., Marchuk D.A., Gadde K.M., et al. Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med 2001;63:300-5.

61. Jorm A.F., Henderson A.S., Jacomb P.A., et al. An association study of a functio￾nal polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Mol Psychiatry 1998;3:449-51.

62. Schins A., Hamulyak K., Scharpe S., et al. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sciences 2004;76:637-50.

63. McFarlane A., Kamath M.V., Fallen E.L., et al. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 2001;142: 617-23.

64. Nakatani D., Sato H., Sakata Y., et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005; 150: 652-58.

65. Meltzer H., Lowy M.T. The serotonin hypothesis of depression. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press; 1987. р. 513-26.

66. Ovigstad E., Brattelid T., Sjaastad I., et al. Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure. Cardiovasc Res 2005;65:869-78.

67. Kaumann A.J. Gs protein-coupled receptors in human heart. In: Kenakin T., Angus J.A., editors. The pharmacology of functional, biochemical, and recombinant receptor systems. Berlin: Springer-Verlag; 2000. р. 73-116.

68. Kaumann A.J., Sanders L. 5-Hydroxytryptamine and human heart function: the role of 5-HT4 receptors. In: Eglen RM, editor. 5-HT4 receptors in the brain and periphery. Berlin: Springer; 1998. р. 127-48.

69. Bruce E.C., Musselman D.L. Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005;67 Suppl 1:S34-S36.

70. Markovitz J.H., Matthews K.A. Platelets and coronary heart disease: potential psychophysiologic mechanism. Psychosom Med1991;53:643-68.

71. Schins A., Honig A., Crijns H., et al. Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link? Psychosom Med 2003;65:729-37.

72. Kuijpers P.M., Hamulyak K., Strik J.J., et al. Beta-thromboglobulin and platelet factor 4 levels in postmyocardial infarction patients with major depression. Psychiatry Res 2002;109:207-10.

73. Laghrissi-Thode F., Wagner W.R., Pollock B.G., et al. Elevated platelet factor 4 and b-thromboglobulin plasma levels in depressed patients with ischemic heart di￾sease. Biol Psychiatry 1997;42:290-5.

74. Musselman D.L., Marzec U., Davidoff M., et al. Platelet activation and secretion in patients with major depression compared to patients with atherosclerosis or renal dialysis treatment. Depression 2002;15:91-101.

75. Serebruany V.L., Glassman A.H., Malinin A.I., et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events. The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) platelet substudy. Circulation 2003;108:939-44.

76. Mulvihill N.T., Foley J.B. Inflammation in acute coronary syndromes. Heart 2002;87:201-4.

77. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003;108:2317-22.

78. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.

79. Kop W.J., Gottdiener J.S. The role of immune system parameters in the relation￾ship between depression and coronary artery disease. Psychosom Med 2005;67 Suppl 1:S37-S41.

80. Pasic J., Levy W.C., Sullivan M.D. Cytokines in depression and heart failure. PsychosomMed 2003;65:181-93.

81. Kop W.J., Gottdiener J.S., Tangen C.M., et al. Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evi￾dence of myocardial ischemia. Am J Cardiol 2002;89:419-24.

82. Schins A., Tulner D., Lousberg R., et al. Inflammatory markers in depressed post￾myocardial infarction patients. J Psychiatr Res 2005;39:137-144.

83. Herbert T.B., Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993; 113: 472-86.

84. Shimbo D., Chaplin W., Crossman D., et al. Role of depression and inflammation in incident coronary heart disease events. Am J Cardiol 2005;96:1016-21.

85. Romanelli J., Fauerbach J.A., Bush D.E., Ziegelstein R.C. The significance of depression in older patients after myocardial infarction. J Am Geriatr Soc 2002;50:817-22.

86. Ziegelstein R.C., Fauerbach J.A., Stevens S.S., et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 60:1818-23.

87. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000;160:2101-7.

88. Glassman A.H., Helzer J.E., Covey L.S., et al. Smoking, smoking cessation, and major depression. JAMA 1990;264:1546-9.

89. Lustman P.J., Anderson R.J., Freedland K.E., et al. Depression and poor glycemic control: a meta-analytic reiew of the literature. Diabetes Care 2000;23:934-42.

90. Rieckmann N., Kronish I.M., Haas D., et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006;152:922-7.

91. Strik J.J.M.H., Honig A., Lousberg R., et al. Clinical correlates of depression following myocardial infarction. Int’l J of Psychiatry in Medicine 2001;31(3):255-64.

92. Shemesh E., Yehuda R., Milo O., et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med 2004;66:521-6.

93. Bunde J., Martin R. Depression and prehospital delay in the context of myocardial infarction. Psychosom Med 2006;68:51-7.

94. Carney R.M., Rich M.W., te Velde A., et al. Major depressive disorder in coronary artery disease. Am J Cardiol1987;60:1273-5.

95. Bush D.E., Ziegelstein R.C., Tayback M., et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001; 8:337-41.

96. Horsten M., Mittleman M.A., Wamala S.P., et al. Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. Eur Heart J 2000;21:1072-80.

97. van Melle J.P., de Jonge P., Spijkerman T.A., et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004;66:814-22.

98. Mayou R.A., Gill D., Thompson D.R., et al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med2000;62:212-9.

99. Lane D., Carroll D., Ring Ch., et al. Mortality and quality of life 12 Months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001;63:221-30.

100. Lane D., Carroll D., Ring Ch., et al. In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. Int J Epidemiol 2002;31:1179-82.

101. Cherrington C.C., Moser D.K., Lennie T.A., Kennedy C.W. Illness representation after acute myocardial infarction: impact on in-hospital recovery. Am J Crit Care 2004;13(2):136-145.

102. Lane D., Carroll D., Lip G.Y.H. Anxiety, depression, and prognosis after myocardial infarction. Is there a causal association? J Am Coll Cardiol 2003;42:1808-10.

103. Stewart R.A.H., North F.M., West T.M., et al. Depression and cardiovascular morbidity and mortality: cause or consequence? Eur Heart J 2003;24:2027-37.

104. Carney R.M., Freedland K.E., Sheps D.S. Depression is a risk factor for mortality in coronary heart disease. Psychosom Med2004;66:799-801.

105. Sorensen C., Friis-Hasche E., Haghfelt T., Bech P. Postmyocardial infarction mortality in relation to depression: a systematic critical review. Psychother Psycho￾som 2005;74:69-80.

106. Frasure-Smith N., Lesperance F. Reflections on depression as a cardiac risk factor. Psychosom Med 2005;67 Suppl 1:S19-S25.

107. Lesperance F., Frasure-Smith N. Depression and coronary artery disease: time to move from observation to trials. CMAJ 2003;168(5):570-571.

108. Grace S.L., Abbey S.E., Kapral M.K., et al. Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol 2005;96:1179-85.

109. Shiotania I., Sato H., Kinjo K., et al. Depressive symptoms predict 12-month pro￾gnosis in elderly patients with acute myocardial infarction. JCardiovasc Risk 2002;9:153-160.

110. Sorensen C., Brandes A., Hendricks O., et al. Depression assessed over 1-year survival in patients with myocardial infarction. Acta Psychiatr Scand 2006;113:290-7.

111. Dickens C., McGowan L., Percival C., et al. Association between depressive episode before first myocardial infarction and worse cardiac failure following infarction. Psychosomatics 2005;46:523-8.

112. Powell L.H., Catellier D., Freedland K.E., et al. Depression and heart failure in patients with a new myocardial infarction. Am Heart J 2005;149:851-5.

113. Rumsfeld J.S., Jones Ph.G., Whooley M.A., et al. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J 2005;150:961-7.

114. Rumsfeld J.S, Magid D.J., Plomondon M.E., et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 2003; 145: 493-9.

115. Дробижев М.Ю. Лечение тианептином (коаксилом) тревожных депрессий у больных ишемической болезнью сердца. Журн неврол психиатр им. С.С. Корсакова 2000;(4): 44-47.

116. Irvine J., Basinski A., Baker B., et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999;61:729-37.

117. Dickens Ch., McGowan L., Percival C., et al. Lack of a close confidant, but not depression, predicts further cardiac events after myocardial infarction. Heart 2004;90:518-22.

118. Seccareccia F., Pannozzo F., Dima F., et al. Heart rate as a predictor of mortality: the MATISS Project. Am J Public Health 2001;91:1258-63.

119. Podrid P.J., Fuchs T., Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990;82:103-10.

120. Palatini P., Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997;11:S19-27.

121. Carney R.M., Freedland K.E., Stein P.K., et al. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000;62:639-47.

122. Stein P.E., Carney R.M., Freedland K.E., et al. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J PsychosomRes 2000;48:493-500.

123. Vigo D.E., Siri L.N., Ladron de Guevara S., et al. Relation of depression to heart rate nonlinear dynamics in patients ≥60 years of age with recent unstable angina pectoris or acute myocardial infarction. Am J Cardiol 2004;93:756-60.

124. Carney R.M., Freedland K.E., Veith R.C., et al. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 1999;45:458-63.

125. Carney R.M., Freedland K.E., Stein Ph.K., et al. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med 2003;65:177-80.

126. Watkins L.L., Blumenthal J.A., Carney R.M. Association of anxiety with reduced baroreflex cardiac control in patients after acute myocardial infarction. Am Heart J 2002;143:460-6.

127. Carney R.M., Blumenthal J.A., Stein Ph.K., et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001;104:2024-28.

128. Pitzalis M.V., Iacoviello M., Todarello O., et al. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am He￾art J 2001;141:765-71.

129. Krittayaphong R., Cascio W.E., Light K.C., et al. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med 1997;59:231-5.

130. Malhotra S., Tesar G.E., Franco K. The relationship between depression and cardiovascular disorders. Curr Psychiatry Rep2000;2(3):241-6.

131. Sloan R.P., Shapiro P.A., Bagiella E., et al. Cardiac autonomic control buffers blood pressure variability responses to challenge: a psychophysiologic model of co￾ronary artery disease. Psychosom Med 1999;61:58-68.

132. Bigger J.T., Fleiss J.L., Rolnitzky L.M., Steinman R.C. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993;21:729-36.

133. Taylor J.A., Carr D.L., Myers C.W., et al. Mechanisms underlying very-low frequency RR - interval oscillations in humans. Circulation 1997;98:547-55.

134. Bonnemeier H., Hartmann F., Wiegand U.K.H., et al. Course and prognostic implications of QT interval and QT interval variability after primary coronary an￾gioplasty in acute myocardial infarction. J Am Coll Cardiol 2001;37:44-50.

135. Vrtovec B., Starc V., Starc R. Beat-to-beat QT interval variability in coronary patients. J Electrocardiol 2000;33:119-25.

136. Muller J.E., Ludmer P.L., Willich S.N., et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-8.

137. Blumenthal J.A., Babyak M.A., Carney R.M., et al. Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc 2004;36(5):746-55.

138. Ruo B., Rumsfeld J.S., Hlatky M.A., et al. Depressive symptoms and health-related quality of life. The Heart and Soul Study. JAMA 2003;290:215-21.

139. Shapiro C.M. Depression and vital exhaustion before and after myocardial infarction. J Psychosom Res 2005;58:391-2.

140. Ickovics J.R., Viscoli C.M., Horwitz R.I. Functional recovery after myocardial in￾farction in men: the independent effects of social class. Ann Intern Med 1997;27(7):518-25. 141. Carney R.M., Blumenthal J.A., Catellier D., et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 2003;92:1277-81.

141. Strik J.J., Denollet J., Lousberg R., Honig A. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003;42:1801-7.

142. Strik J.J. Lousberg R., Cheriex E.C., Honig A. One year cumulative incidence of depression following myocardial infarction and impact on cardiac outcome. J Psychosom Res 2004;56:59-66.

143. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819-25.

144. van Melle J.P., de Jonge P., Ormel J., et al. Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J 2005;26:2650-6.

145. Ziegelstein R.C., Thombs B.D. The brain and the heart: the twain meet. Eur Heart J 2005;26:2607-8.

146. Steptoe A., Whitehead D.L. Depression, stress, and coronary heart disease: the need for more complex models. Heart 2005;91:419-20.

147. Петрова М. М., Айвазян Т. А., Фандюхин С. А. Качество жизни у мужчин, перенесших инфаркт миокарда. Кардиология 2000;(2):65-6.

148. Хадзегова А.Б., Айвазян Т.А., Померанцев В.П. и соавт. Динамика психологического статуса и качества жизни больных инфарктом миокарда в за- висимости от тяжести течения постинфарктного периода. Кардиология 1997;(1):37-40.

149. Plevier C.M., Mooy J.M., Marang-Van de Mheen P.J., et al. Persistent impaired functioning in survivors of a myocardial infarction? Qual Life Res 2001;10:123-32.

150. Simpson E., Pilote L. Quality of life after acute myocardial infarction: a systematic review. Can J Cardiol 2003;19(5):507-11.

151. Brown N., Melville M., Gray D., et al. Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart 1999;81:352-8.

152. Westin L., Nilstun T., Carlsson R., Erhardt L. Patients with ischemic heart disease: quality of life predicts long-term mortality. Scand Cardiovasc J 2005;39(1- 2):50-4.

153. de Jonge P., Spijkerman T.A., van den Brink R..H, Ormel J. Depression after myocardial infarction is a risk factor for declining health related quality of life and increased disability and cardiac complaints at 12 months. Heart 2006;92(1):32-9.

154. Swenson J.R., O’Connor Ch.M., Barton D., et al. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003;92:1271-1276.

155. Fauerbach J.A., Bush D.E., Thombs B.D., et al. Depression following acute myocardial infarction: a prospective relationship with ongoing health and function. Psychosomatics 2005;46:355-61.

156. Brink E., Grankvist G., Karlson B.W., Hallberg L. R.-M. Health-related quality of life in women and men one year after acute myocardial infarction. Qual Life Res 2005;14:749-57.

157. Rumsfeld J.S., Magid D.J., Plomondon M.E., et al. Predictors of quality of life following acute coronary syndromes. Am J Cardiol 2001;88:781-4.

158. Luutonen S., Holm H., Salminen J.K., et al. Inadequate treatment of depression after myocardial infarction. Acta Psychiatr Scand 2002;106:434-9.

159. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000;22:370-9.

160. Погосова Г.В., Жидко Н.И., Красницкий В.Б. и соавт. Клиническая эффективность тианептина у больных ишемической болезнью сердца с коморбидной депрессией. Кардиология 2004;(3):20-24.

161. Taylor C.B., Youngblood M.E., Catellier D., et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005;62:792-8.

162. Jackson J.L., DeZee K., Berbano E. Can treating depression improve disease outcomes? Ann Intern Med 2004;140:1054-6.

163. Sheps D.S., Freedland K.E., Golden R.N., McMahon R.P. ENRICHD and SADHART: implications for future biobehavioral intervention efforts. Psychosom Med 2003;65:1-4.

164. Carney R.M., Blumenthal J.A., Freedland K.E., et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004;66:466-74.

165. Watkins L.L., Blumenthal J.A., Davidson J.R., et al. Antidepressant use in coronary heart disease patients: impact on survival. American Psychosomatic Society 64th Annual Meeting. Denver, Colorado. March 1-4, 2006. Abstract 1553. Available from URL: AbstractsForJournal06.pdf

166. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: Медицинское информационное агентство; 2003.

167. Ушкалова Е.А., Ушкалова А.В. Фармакотерапия депрессии у кардиологических больных. Трудный пациент 2006;(1):50-7.

168. Roose S.P., Spatz E. Treating depression in patients with ischaemic heart disease: which agents are best to use and to avoid? Drug Safety 1999;20(5):459-65.

169. Довженко Т.В. Взаимосвязь аффективных и сердечно–сосудистых расстройств. Социальная и клиническая психиатрия 2005;(3):69-80.

170. Мосолов С.Н., Аведисова А.С., Вертоградова О.П., и соавт. Клиническая эффективность и переносимость тианептина при депрессии (открытое российское мультицентровое исследование). Журн неврол психиатр им. С.С. Корсакова 2003;103(8):29-34.

171. Погосова Н.В. Депрессии у кардиологических больных: современное состояние проблемы и подходы к лечению. Кардиология 2004;(1):88-92.

172. Juvent M., Douchamps J., Delcourt E., et al. Lack of cardiovascular side effects of the new tricyclic antidepressant tianeptine. A double-blind, placebo-control￾led study in young healthy volunteers. Clin Neuropharmacol 1990;13(1):48.

173. Довженко Т.В., Тарасова К.В., Васюк Ю.А., Краснов В.Н., и соавт. Хроническая сердечная недостаточность ишемического генеза и расстройства и аффективного спектра. Сердце 2003;(6):304-6.

174. Кириченко А.А., Эбзеева Е.Ю. Роль депрессивных расстройств при гипертонической болезни и возможности их коррекции: оценка влияния коаксила. Кардиология 2002;(10):36-40.

175. Довженко Т.В., Тарасова К.В., Нестерова Е.А., и соавт. Антидепрессанты коаксил и золофт в комплексном лечении больных артериальной гипертензией с расстройствами аффективного спектра. Росс мед журн 2004;(1):15-9.

176. Ibrahimagic O.C., Sinanovic O., Smajlovic D. Anxiety in acute phase of ischemic stroke and myocardial infarction. Med Arh 2005;59(6):366-9.

177. An K., De Jong M.J., Riegel B.J., et al. A cross-sectional examination of changes in anxiety early after acute myocardial infarction. Heart Lung 2004;33:75- 82.

178. Grace S.L., Abbey S.E., Irvine J., et al. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom 2004;73:344-352.

179. Kim K.A., Moser D.K., Garvin B.J., et al. Differences between man and women in anxiety early after acute myocardial infarction. Am J Crit Care 2000;9:245- 53.

180. Bjerkeset O., Nordahl H.M., Mykletun A., et al. Anxiety and depression following myocardial infarction: gender differences in a 5-year prospective study. J Psychosom Res 2005;58:153-161.

181. Frazier S.K., Moser D.K., O’Brien J.L., et al. Management of anxiety after acute myocardial infarction. Heart Lung 2002;31:411-20.

182. O'Brien J.L., Moser D.K., Riegel B., et al. Comparison of anxiety assessments between clinicians and patients with acute myocardial infarction in cardiac critical care units. Am J Crit Care 2001;10:97-103.

183. De Jong M.J., Moser D.K., An K., Chung M.L. Anxiety is not manifested by elevated heart rate and blood pressure in acutely ill cardiac patients. Eur J Cardiovasc Nursing 2004;3:247-253.

184. Moser D.K., Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med 1996;58:395- 401.

185. Benninghoven D., Kaduk A., Wiegand U., et al. Influence of anxiety on the course of heart disease after acute myocardial infarction – risk factor or protective function? Psychother Psychosom 2006;75:56-61.

186. Лебедева Н.Б., Лебедев О.В., Бернс С.А. и соавт. Взаимосвязь электрофизиологических маркеров аритмогенности и особенностей психоэмоционального статуса у больных инфарктом миокарда. Кардиология 2003;(2):70- 71.

187. Denoillet J., Brutsaert D.L. Personality, disease severity, and the risk of long-term cardiac events in patients with decreased ejection fraction after myocardial infarction. Circulation 1998;97:167-73.

188. Frasure-Smith N., Lesperance F. Depression, and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003;60:627-36.

189. Lane D., Carroll D., Ring Ch., et al. Do depression and anxiety predict recurrent coronary events 12 months after myocardial infarction? Q J Med 2000;93:739- 44.

190. Carinci F., Nicolucci A., Ciampi A., et al. Role of interactions between psychological and clinical factors in determining 6-month mortality among patients with acute myocardial infarction. Application of recursive partitioning techniques to the GISSI-2 database. Eur Heart J 1997;18:835-45.

191. Herrmann C., Brand-Driehorst S., Buss U., Ruger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exerciese testing. J Psychosom Res 2000;48:455-62.

For citation:

Vasyuk Y.A., Lebedev A.V. DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II. Rational Pharmacotherapy in Cardiology. 2007;3(4):39-45. (In Russ.)

Views: 504

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)